Synthesis and structure–activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors-Reference-Cited by-同舟云学术

Synthesis and structure–activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors

Published:2014-10 Issue:19 Volume:22 Page:5513-5529
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Nagao Satoshi,Yamane Yoshinobu,Funasaka Setsuo,Tanaka Keigo,Miyazaki Kazuki,Kotake Yoshihiko,Kamata Jun-ichi,Watanabe-Miyano Saori,Toyama Osamu,Ozawa Yoichi,Mizui Yoshiharu,Okamoto Kiyoshi,Ito Daisuke

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference30 articles.

1. Exploiting tumour hypoxia in cancer treatment

2. Treatment Resistance of Solid Tumors

3. Review: Implications of In Vitro Research on the Effect of Radiotherapy and Chemotherapy Under Hypoxic Conditions

4. HIF-1 and tumor progression: pathophysiology and therapeutics

5. Evaluation of HIF-1 inhibitors as anticancer agents

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, Binding Affinity Analysis, and 18 F Radiosynthesis of Small‐Molecular‐Weight HIF‐1α‐Binding Compounds;ChemMedChem;2021-10-28

2. Revealing quinquennial anticancer journey of morpholine: A SAR based review;European Journal of Medicinal Chemistry;2019-04

3. Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A “structure-activity relationship” perspective;Medicinal Research Reviews;2017-12-26

4. Design, Synthesis and Structure-Activity Relationship Studies of Novel 4 (1-adamantyl) Phenyl Analogues as HIF-1α Inhibitors;Medicinal Chemistry;2016-05-09

5. Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides;PLOS ONE;2016-01-05